Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Indivior (INDV1) Price & Analysis

INDV1 Stock Chart & Stats

MX$600.10MX$0.00(0.00%)
At close: 4:00 PM EDT
No data to display
Day’s Range
MXN 600.10 - MXN 600.10
52-Week Range
MXN 600.10 - MXN 645.80
Previous Close
MXN 600.10
Volume
N/A
Average Volume (3M)
0
Market Cap
MXN 78.43B
Enterprise Value
MXN 4.57B
Total Cash (Recent Filing)
MXN 305.00M
Total Debt (Recent Filing)
MXN 501.00M
Price to Earnings (P/E)
9.7
Beta
-0.02
Next Earnings
Mar 04, 2027
EPS Estimate
18.62
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

SUBLOCADE Growth And Protection

SUBLOCADE combines strong recent growth, leading market share, record new patient starts, and a long patent runway. These features support durable pricing power and patient retention while limiting near-term generic pressure, making the product a credible multi-year foundation for revenue and cash generation.

Improved Profitability

The sharp improvement in profitability indicates that Indivior is converting product growth into substantial operating earnings rather than relying only on higher sales. Sustained margin expansion can strengthen internal funding capacity, support investment in commercialization, and improve resilience across the business cycle.

Merger Scale And Synergies

Combining Indivior with Supernus would broaden the CNS portfolio, increase commercial scale, and add identified cost savings targeted within 12 months. A larger platform may diversify growth opportunities and improve operating leverage, while the projected synergy plan provides a concrete path to additional profitability.

Bears Say

Negative Shareholders’ Equity

Negative equity weakens the balance sheet’s financial cushion and makes conventional leverage measures less informative. Combined with debt, it leaves less flexibility to absorb earnings or cash-flow setbacks, fund unexpected needs, or pursue growth without increasing financial pressure on the company.

Volatile Cash Generation

Inconsistent operating and free cash flow reduces confidence that reported earnings will reliably translate into funds available for debt reduction, investment, or shareholder returns. The sharp variation across periods makes planning more difficult and increases sensitivity to any slowdown in product performance.

SUBLOCADE Concentration And Merger Execution

The combined company would depend heavily on one product while simultaneously integrating two commercial organizations. Any slowdown in SUBLOCADE adoption, payer access, or market share could have an outsized effect, and execution demands may delay the realization of expected strategic and cost benefits.

Indivior News

INDV1 FAQ

What was Indivior’s price range in the past 12 months?
Indivior lowest stock price was Mex$600.10 and its highest was Mex$645.80 in the past 12 months.
What is Indivior’s market cap?
Indivior’s market cap is Mex$78.43B.
When is Indivior’s upcoming earnings report date?
Indivior’s upcoming earnings report date is Mar 04, 2027 which is in 123 days.
How were Indivior’s earnings last quarter?
Indivior released its earnings results on Oct 29, 2026. The company reported Mex$24.924 earnings per share for the quarter, beating the consensus estimate of Mex$20.034 by Mex$4.89.
Is Indivior overvalued?
According to Wall Street analysts Indivior’s price is currently Undervalued.
Does Indivior pay dividends?
Indivior does not currently pay dividends.
What is Indivior’s EPS estimate?
Indivior’s EPS estimate is 18.62.
How many shares outstanding does Indivior have?
Indivior has 118,035,270 shares outstanding.
What happened to Indivior’s price movement after its last earnings report?
Indivior reported an EPS of Mex$24.924 in its last earnings report, beating expectations of Mex$20.034. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Indivior?
Currently, no hedge funds are holding shares in MX:INDV1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology